One-on-one care management and procurement of Naloxone for ambulatory use
| Autor: | John Whittington, Karla Zimmermann, Stacey Berg, Kathleen Whittington, Holly Case, Joel Porter, Richard Whittington |
|---|---|
| Rok vydání: | 2017 |
| Předmět: |
Male
medicine.medical_specialty medicine.drug_class Narcotic Antagonists 01 natural sciences 03 medical and health sciences 0302 clinical medicine Naloxone Intervention (counseling) medicine Ambulatory Care Humans Pain Management 030212 general & internal medicine 0101 mathematics Medical prescription business.industry 010102 general mathematics Public Health Environmental and Occupational Health Chronic pain General Medicine Middle Aged medicine.disease Substance abuse Analgesics Opioid Opioid Ambulatory Emergency medicine Female Chronic Pain business Opioid antagonist medicine.drug |
| Zdroj: | Journal of public health (Oxford, England). 40(4) |
| ISSN: | 1741-3850 |
| Popis: | Background Morbidity and mortality from prescription opioids has reached unprecedented levels. Opioids remain part of chronic pain treatment in primary care. This study was designed to determine whether one-on-one care management increases procurement of Naloxone, an opioid antagonist shown to reduce morbidity and mortality in opioid overdoses. Methods Participants included all patients ≥18 years enrolled in a primary care-based chronic pain management program and who were prescribed a daily dose of opioids for treatment of chronic pain. In total, 153 patients chose to participate. Each had a 1 h one-on-one education meeting with a registered nurse. Results Among the enrolled, eight patients (5.2%) had procured Naloxone prior to intervention. Overall, 31 additional patients (20.2%) procured Naloxone after intervention, a 288% relative improvement in the attainment of Naloxone (P < 0.0001) (χ2 = 29.032 with 1 degree freedom). Of the 114 participants who never procured Naloxone, 69.3% believed it was unnecessary, 20% forgot about Naloxone, 8% said it was cost prohibitive, 3.5% had access concerns and 0.9% had concerns about side effects. Conclusion Direct one-on-one nurse care management sessions were associated with an increased procurement of Naloxone in a primary care-based pain management program. A significant number of patients believed Naloxone was unnecessary after the intervention. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|